Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens.
about
Dyslipidemia and adherence to the Mediterranean diet in Croatian HIV-infected patients during the first year of highly active antiretroviral therapy.Switch studies: a review.HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort studyA Study to Evaluate Lipid Profile in Treatment Naïve HIV Positive Patients.Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load.Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy
P2860
Q33747646-0AA4CE9A-383F-4153-B049-E248CDC4A370Q34636824-8F166CFF-3096-47B8-A34A-C36D23BE0EDDQ36842181-82FD2B3C-DE05-4227-AD5A-2F11168A7DA3Q37521981-F5A234A3-3B6D-4FC7-9648-7CEE0593ED39Q40389936-03EE99EF-0504-4EB0-BFFF-9CD523F5FC87Q43974789-86BAAFED-472A-41AF-A611-C992BBD9D28DQ44510170-BE0F3C8B-AE10-4919-97A5-4A15FB1D9FFBQ44893786-DC48F022-E72A-4D79-98F4-2B16A44CC79EQ45723089-B8AC64C5-B194-4455-AA1F-B6322604738DQ46474207-D57F823C-C305-4B04-84FD-E6D48C9ABEAAQ51709478-AB4D1BCA-CF25-4C2D-87CE-3278CB5429E3Q58322336-1AB6A321-4B9F-4498-B9B9-951EB868C087
P2860
Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Increase of atherogenic plasma ...... inhibitor-containing regimens.
@en
Increase of atherogenic plasma ...... inhibitor-containing regimens.
@nl
type
label
Increase of atherogenic plasma ...... inhibitor-containing regimens.
@en
Increase of atherogenic plasma ...... inhibitor-containing regimens.
@nl
prefLabel
Increase of atherogenic plasma ...... inhibitor-containing regimens.
@en
Increase of atherogenic plasma ...... inhibitor-containing regimens.
@nl
P2093
P1476
Increase of atherogenic plasma ...... inhibitor-containing regimens.
@en
P2093
P304
P356
10.1097/00042560-200010010-00017
P407
P577
2000-10-01T00:00:00Z